Low-voltage areas, atrial cardiomyopathy score, and outcomes in patients with preserved ejection fraction after catheter ablation of atrial fibrillation
- PMID: 40734750
- PMCID: PMC12302140
- DOI: 10.1016/j.hroo.2025.04.002
Low-voltage areas, atrial cardiomyopathy score, and outcomes in patients with preserved ejection fraction after catheter ablation of atrial fibrillation
Abstract
Background: Left atrial low-voltage areas (LVAs) and the postprocedural atrial cardiomyopathy (AC) score-which incorporates echocardiographic data and brain natriuretic peptide levels-are linked to outcomes in patients undergoing catheter ablation of atrial fibrillation (AF). However, voltage mapping requires considerable time and cost, and the optimal prognostic predictor for patients with preserved left ventricular ejection fraction (LVEF) after AF ablation remains unclear.
Objective: This study analyzed the relationship between LVAs, the AC score, and outcomes among patients with preserved LVEF after AF ablation.
Methods: We retrospectively analyzed 270 patients with preserved LVEF who underwent AF ablation. Blood tests and transthoracic echocardiography were performed 2 weeks before and 3 months after ablation. We defined LVAs as regions with a bipolar peak-to-peak voltage of <0.50 mV. Patients were divided into 2 groups: no LVA (LVA size <5 cm2, n = 207) and LVA (≥5 cm2, n = 63).
Results: Multivariate analysis revealed that both the postprocedural AC score and the presence of LVA were independently associated with AF recurrence (hazard ratio [HR] = 1.49, P < .001; HR = 1.05, P = .004). However, the postprocedural AC score was independently associated with cardiovascular events (HR = 2.22, P < .001), whereas the presence of LVA was not (HR = 1.13, P = .796).
Conclusion: The presence of LVA and the postprocedural AC score are associated with AF recurrence. However, the AC score is a more cost-effective and stronger predictor of cardiovascular events in patients with preserved LVEF after AF ablation than the presence of LVA.
Keywords: Atrial cardiomyopathy; Atrial fibrillation; Catheter ablation; Low-voltage area; Reverse remodeling.
© 2025 Heart Rhythm Society. Published by Elsevier Inc.
Figures



Similar articles
-
Non-invasive prediction of atrial cardiomyopathy characterized by multipolar high-density contact mapping.J Interv Card Electrophysiol. 2025 Jun;68(4):865-876. doi: 10.1007/s10840-025-02001-2. Epub 2025 Feb 3. J Interv Card Electrophysiol. 2025. PMID: 39899140 Free PMC article.
-
Automatically Derived Unipolar Low-Voltage-Area Burden for Predicting Atrial Fibrillation Ablation Outcomes.Can J Cardiol. 2025 Jul 16:S0828-282X(25)00547-1. doi: 10.1016/j.cjca.2025.06.077. Online ahead of print. Can J Cardiol. 2025. PMID: 40680882
-
Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trial.Nat Med. 2025 May;31(5):1661-1667. doi: 10.1038/s41591-025-03674-y. Epub 2025 Apr 30. Nat Med. 2025. PMID: 40307511 Free PMC article. Clinical Trial.
-
Low voltage area guided substrate modification in nonparoxysmal atrial fibrillation: A systematic review and meta-analysis.J Cardiovasc Electrophysiol. 2023 Feb;34(2):455-464. doi: 10.1111/jce.15764. Epub 2022 Dec 9. J Cardiovasc Electrophysiol. 2023. PMID: 36453469
-
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340. Health Technol Assess. 2008. PMID: 19036232
References
-
- Hindricks G., Potpara T., Dagres N., et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373–498. - PubMed
-
- Goette A., Corradi D., Dobrev D., et al. Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS) Europace. 2024;26 - PMC - PubMed
-
- Yamaguchi T. Atrial structural remodeling and atrial fibrillation substrate: a histopathological perspective. J Cardiol. 2025;85:47–55. - PubMed
LinkOut - more resources
Full Text Sources